药物中的钠与高血压——医疗卫生当局、制药公司和医生需要认真关注药物中的钠对心血管健康的威胁

原文传递

导出

摘要实验、临床和流行病学研究一致表明过多盐摄入会促进高血压的发生。由于世界范围内62％的卒中与49％心脏事件均归因于高血压，所以对高血压的预防和治疗可以大幅度降低上述事件的发生率。

作者 Pasquale Strazzullo 丑赛(译) 严晓伟(校)

机构地区 Department of Clinical Medicine and Surgery 北京协和医院心血管内科

出处《英国医学杂志中文版》 2014年第1期4-5,共2页 The BMJ Chinese Edition

关键词高血压心血管健康医疗卫生制药公司药物医生流行病学心脏事件

参考文献7

1He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. } Hum. Hypertens 2009 ;23 :363-84.
2WHO. Guideline: sodium intake for adults and children. 2012.
3Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2013 ESH/ESC guidelines for the management of arterial hypertension. } Hypertens 2013 ;31: 1281-357.
4George J, Majeed W, Mackenzie IS, MacDonald TM, Wei L. Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control study. 8M} 2013 ;347: f6954.
5Ubeda A, Llopico J, Sanchez MT. Blood pressure reduction in hypertensive patients after withdrawal of effervescent medication. Pharmacoepidemiol Drug Sal 2009 ; 18 : 417 -9.
6Food and Drug Administration. FDA enhances safeguards for consumers who may have special sensitivities 1.0 certain commonly used over-the-counter drug ingredients. 2004.
7European Commission. Medicinal products for human use: safety, environment and information. Excipients in the label and package leaflet of medicinal products for human use. 2003.

英国医学杂志中文版

2014年第1期

内容加载中请稍等...